 Itamar Medical Ltd. ITMR ITMR, a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the closing of its upsized public offering of 2,927,267 American Depositary Shares ADSs, which includes the full exercise of the underwriters option to purchase 381,817 additional ADSs, at a public offering price of 13.75 per ADS, for total gross proceeds of approximately 40.25 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Itamar Medical. Each ADS represents 30 ordinary shares of Itamar Medical. All ADSs are being offered by Itamar Medical. 